118 – Digital Tools in Surveillance (S8E13)

This episode explores how digital technologies and data analytics are transforming pharmacovigilance and post-market surveillance. We discuss the use of mobile apps, wearables, AI-driven analytics, and big data integration in detecting adverse events and improving patient safety.

The conversation highlights real-world applications, such as the FDA's Sentinel Initiative, AI signal detection, and real-time patient monitoring tools. Case studies are used to illustrate the impact and challenges of these technologies. The episode emphasizes the potential of digital tools to enhance the efficiency and effectiveness of drug safety monitoring while also acknowledging the ethical considerations and the need for human oversight.